Topics

FDA expands use of Regeneron, Sanofi's Dupixent

06:21 EDT 27 Jun 2019 | SmartBrief

Regeneron Pharmaceuticals and Sanofi's Dupixent has been approved by the FDA for use in adult patients with uncontrolled chro -More

Original Article: FDA expands use of Regeneron, Sanofi's Dupixent

NEXT ARTICLE

More From BioPortfolio on "FDA expands use of Regeneron, Sanofi's Dupixent"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...